癌症与动脉粥样硬化:共享机制与双向作用探讨  

Cancer and atherosclerosis:sharing mechanisms and bidirectional effects

作　　者：王思奇 王雪羽 钟珊 张健 田进伟[1,2] WANG Si-qi;WANG Xue-yu;ZHONG Shan;ZHANG Jian;TIAN Jin-wei(Department of Cardiology,The Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin,150081,China;Heilongjiang Provincial Key Laboratory of Panvascular Diseases,Heilongjiang Harbin 150081,China;School of Pharmacy,East China University of Science and Technology,Shanghai,200237,China)

机构地区：[1]哈尔滨医科大学附属第二医院心内科,黑龙江哈尔滨150081 [2]黑龙江省泛血管疾病重点实验室,黑龙江哈尔滨150081 [3]华东理工大学药学院,上海200237

出　　处：《内科急危重症杂志》2024年第6期493-500,共8页Journal of Critical Care In Internal Medicine

基　　金：国家自然科学基金项目(U21A2039,82370343);黑龙江省自然科学基金(ZD2023H005)。

摘　　要：癌症和动脉粥样硬化性心血管疾病(ASCVD)是导致全球人口死亡的最主要原因。随着人口老龄化和医疗水平的提高,癌症和ASCVD患者的数量逐渐增加,患者的生存时间延长,从而导致这两类疾病共病现象的发生。其次,由于癌症和ASCVD具有某些共同的危险因素和病理生理过程,进一步增加了癌症和ASCVD的共患病患者数。因此,如何管理越来越多的癌症-ASCVD共患病患者成为了前所未有的挑战。为了更全面、有效及科学地管理癌症-ASCVD共患病患者,本文针对癌症与动脉粥样硬化(AS)的相互关系进行综述。Cancer and atherosclerotic cardiovascular disease(ASCVD)are the leading causes of death worldwide.With the aging of the population and the improvement of medical level,the number of patients with cancer and atherosclerotic heart disease is gradually increasing,and the survival time of patients is lengthening,which leads to the occurrence of comorbidity of these two diseases.Secondly,because cancer and ASCVD share certain risk factors and pathophysiological processes,the number of co-patients with cancer and ASCVD is further increased.Therefore,how to manage the growing number of patients with cancer-ASCVD comorbid has become an unprecedented challenge.In order to manage patients with cancer-ASCVD comorbid more comprehensively,effectively and scientifically,this article reviews the relationship between cancer and atherosclerosis.

关 键 词：癌症 肿瘤 动脉粥样硬化 

分 类 号：R541.4[医药卫生—心血管疾病]